AN ANTICOAGULANT PREPARATION

For prophylaxis or treatment of coagulation disorders or cancer an extrinsic pathway inhibitor (EPI) is administered together with heparin or other mucopolysaccharide to the patient. Thereby an increase in coagulant activity is obtained as well as an increase of half-life of injected EPI in plasma....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	NORDFANG, OLE, JUUL
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	For prophylaxis or treatment of coagulation disorders or cancer an extrinsic pathway inhibitor (EPI) is administered together with heparin or other mucopolysaccharide to the patient. Thereby an increase in coagulant activity is obtained as well as an increase of half-life of injected EPI in plasma. Un inhibiteur à trajectoire extrinsèque (EPI) est administré avec de l'héparine ou autre mucopoly-saccharide à un patient dans la prophylaxie ou le traitement de troubles de la coagulation ou de cancers. Une augmentation de l'activité coagulante est ainsi obtenue ainsi qu'une augmentation de la demi-vie de l'EPI injecté dans le plasma.